--- title: "Dragon and Tiger List | ALK (002940) hit the limit down, with the top 5 sell orders totaling 123 million yuan. Reason for being on the list: The daily decline deviation reached 7% for the top 5 securities" type: "News" locale: "en" url: "https://longbridge.com/en/news/287348092.md" description: "ALK (002940) fell to the daily limit on May 22, closing at 41.09 yuan, with a circulating market value of 7.613 billion yuan. Data from the trading leaderboard shows a buying amount of 80.6742 million yuan, a selling amount of 131 million yuan, and a net buying amount of -50.6838 million yuan. The top 5 selling seats collectively sold 123 million yuan, mainly dominated by the Shenzhen Stock Connect dedicated seats. The expected operating revenue for 2024 is 1.538 billion yuan, with a net profit of 80 million yuan, both showing a downward trend" datetime: "2026-05-22T10:36:33.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/287348092.md) - [en](https://longbridge.com/en/news/287348092.md) - [zh-HK](https://longbridge.com/zh-HK/news/287348092.md) generator: "portal-rs" --- # Dragon and Tiger List | ALK (002940) hit the limit down, with the top 5 sell orders totaling 123 million yuan. Reason for being on the list: The daily decline deviation reached 7% for the top 5 securities According to Tongbi Finance, on May 22, ALK (002940) made it to the list of top stocks. The reason for being listed: this stock had a daily decline deviation of 7%, ranking among the top 5 securities. The buying amount on the list was 80.6742 million yuan, the selling amount was 131 million yuan, and the net buying amount was -50.6838 million yuan. The top 5 buying amounts totaled 80.6536 million yuan. Among them, the first buying position was for institutional use, with a purchase of 22.5184 million yuan; the second buying position was from Shenwan Hongyuan Securities Co., Ltd. Nantong Branch, with a purchase of 16.6698 million yuan; the third buying position was for institutional use, with a purchase of 16.0167 million yuan; the fourth buying position was for Shenzhen Stock Connect, with a purchase of 13.6079 million yuan; the fifth buying position was for institutional use, with a purchase of 11.8407 million yuan. The top 5 selling amounts totaled 123 million yuan. Among them, the first selling position was for Shenzhen Stock Connect, with a sale of 37.5192 million yuan; the second selling position was from Shanghai Securities Co., Ltd. Shenzhen Jintian Road Securities Business Department, with a sale of 26.6962 million yuan; the third selling position was for institutional use, with a sale of 22.7913 million yuan; the fourth selling position was from Kaiyuan Securities Co., Ltd. Xi'an Taihua Road Securities Business Department, with a sale of 21.0234 million yuan; the fifth selling position was for institutional use, with a sale of 14.8547 million yuan. As of the close on May 22, ALK (002940) hit the daily limit down, with a closing price of 41.09 yuan, a circulating market value of 7.613 billion yuan, and a turnover rate of 9.1%. *Tongbi Finance Tip:* *ALK (002940.SZ) is projected to have an operating income of 1.538 billion yuan in 2024, with an operating income growth rate of -5.41%. The net profit attributable to the parent company is expected to be 80 million yuan, with a net profit growth rate of -41.94%, and a return on net assets of 5.05%.* *In the first half of 2025, the company's operating income is expected to be 724 million yuan, with an operating income growth rate of -14.52%. The net profit attributable to the parent company is expected to be 66 million yuan, with a net profit growth rate of -3.19%.* *Currently, the company belongs to the healthcare industry, with main product types including antibiotic anti-infection preparations, digestive system preparations, blood system preparations, pharmaceutical distribution, pharmaceutical intermediates, active pharmaceutical ingredients, and specialty preparations. The 2024 report indicates that the main composition of its business is active pharmaceutical ingredients: 48.6%; preparations: 35.57%; specialty intermediates: 13.01%; other businesses: 1.61%; pharmaceutical excipients: 1.21%.* ### Related Stocks - [002940.CN](https://longbridge.com/en/quote/002940.CN.md) ## Related News & Research - [Negative Link Announces Global Expansion and Next Phase of Growth](https://longbridge.com/en/news/296644416.md) - [US health agencies report 55 cases of E. coli and salmonella infections tied to alfalfa sprouts](https://longbridge.com/en/news/296645342.md) - [CDC lifts beneficial stake in Exosens to 11.71% of capital, 13.87% of voting rights](https://longbridge.com/en/news/296499698.md) - [REG - Aberdeen Asian Inc - Director/PDMR Shareholding](https://longbridge.com/en/news/296505605.md) - [Frozen blueberries recall categorized under FDA's highest Class I risk level](https://longbridge.com/en/news/296506599.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**